Polyoxygenated sesquiterpenoids from Salvia castanea and their potential anti-Alzheime's disease bioactivities

Pan-Jie Su,Zong-Ping Zhang,Wen-Bo Cui,Xu Liu,Ru-Yue Wang,De-Juan Zhi,Feng-Ming Qi,Xiao-Han Chen,Yue-Qian Li,Komi Djimabi,Yuan-Qiang Guo,Zhan-Xin Zhang,Dong-Qing Fei

DOI: https://doi.org/10.1016/j.fitote.2021.104867

IF: 3.204

2021-06-01

Fitoterapia

Abstract:<p><em>Salvia castanea</em> (Family Labiatae), a perennial fragrant herb with castaneous flowers, is mainly distributed in areas with an altitude of 2500–3750 m. The roots of this plant were used as a tea drink by local residents to strengthen physical health. The aim of present study was to acquire secondary metabolites of the ethanol extract obtained from the whole plant of <em>S. castanea</em> and to evaluate their potential anti-Alzheimer's disease. Six new sesquiterpene lactones, salcastanins A-F (<strong>1</strong>–<strong>6</strong>), together with three known guaiane-type sesquiterpenoids nubiol (<strong>7</strong>), nubdienolide (<strong>8</strong>), and nubenolide (<strong>9</strong>), were separated from the whole plant of <em>S. castanea.</em> The structures of these compounds were determined by HRESIMS and NMR experiments. The absolute configurations of <strong>1</strong>–<strong>6</strong> were ascertained by electronic circular dichroism (ECD) experiments. The humanized <em>Caenorhabditis elegans</em> AD pathological model was used to evaluate anti-Alzheimer's disease (AD) activities of <strong>1–9</strong>. The results showed the compounds <strong>1</strong>–<strong>3</strong> and <strong>7</strong> significantly delayed AD-like symptoms of worm paralysis phenotype, which could be used as novel anti-AD candidates.</p>

pharmacology & pharmacy,chemistry, medicinal